Abstract:MicroRNAs (miRNAs) are 19-25 nucleotides non-coding RNAs that control diverse cellular events through multiple target mRNAs. Dysregulation of specific spectrum of miRNAs in human malignancies is frequently observed, suggesting that they may play a new layer of regulation as oncogenes or tumor suppressors. Apart from the functional role in embryonic development and tumorigenesis, the imprinted H19 gene also exerts as a primary source for miR-675 biosynthesis. As detected by quantitative real-time PCR, both H19 and miR-675 were overexpressed in human colon cancer cell lines (CloneA, MIP101 and SW480) as well as in primary human colorectal cancer tissues; the miR-675 level is positively correlated with the H19 expression level. Ectopic H19 expression by transfection with H19 expression plasmid induced miR-675 expression while H19 knockdown by using H19 siRNA decreased miR-675 expression in colon cancer cells. For biological function of miR-675, ectopic miR-675 expression by transfection with miR-675 precursor increased cell proliferation and anchorage-independent growth of colon cancer cells while miR-675 knockdown by using miR-675 inhibitor suppressed the growth of cells. Moreover, miR-675 overexpression decreased the luciferase activity of a reporter construct comprising the 3\#8217;untranslated region (3\#8217;UTR) of the Rb mRNA. By Western blot analysis, miR-675 overexpression also suppressed RB protein level in cells. These data show, for the first time, that H19-derived miR-675 is involved in colorectal cancer development and may serve as the potential therapeutic targets for colorectal cancer. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 2532.

The Mir-17-92 Cluster Of Micrornas Confers Tumorigenicity By Inhibiting Oncogene-Induced Senescence

Data from the &Lt;i>mir-17-92</i> Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence

Data from The <i>miR-17-92</i> Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence

Cancer esearch cular and Cellular Pathobiology miR-1792 Cluster of MicroRNAs Confers Tumorigenicity R nhibiting Oncogene-Induced Senescence

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Supplementary Figures 1-6 from The <i>miR-17-92</i> Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence

Role of Mir-17-92 Gene Cluster in Tumor Development and Progression

H19-Derived Mir-675 Functions As An Oncogenic Microrna In Human Colorectal Cancers Through Targeting The Rb Tumor Suppressor

Feud or Friend? the Role of the Mir-17-92 Cluster in Tumorigenesis

Mir-22 Represses Cancer Progression by Inducing Cellular Senescence

Mir-34A Induces Cellular Senescence Via Modulation of Telomerase Activity in Human Hepatocellular Carcinoma by Targeting FoxM1/c-Myc Pathway

miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.

Activation of the miR-371/372/373 miRNA Cluster Enhances Oncogenicity and Drug Resistance in Oral Carcinoma Cells

Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review)

The Mir-17-92 Microrna Cluster is Regulated by Multiple Mechanisms in B-cell Malignancies.

miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways

MicroRNA-17~92 Inhibits Colorectal Cancer Progression by Targeting Angiogenesis

Oncogenic Mir-17/20A Forms a Positive Feed-forward Loop with the P53 Kinase DAPK3 to Promote Tumorigenesis*

Mir-152 As a Tumor Suppressor Microrna: Target Recognition and Regulation in Cancer.

The miR‐15a/16 gene cluster in human cancer: A systematic review